The 222 Shift: Inside the Far-UVC Wavelength Quietly Redefining Sterilization
- Life Scan Medical

- 3 days ago
- 7 min read

For nearly a century, "UVC disinfection" meant one thing: a mercury-vapor tube glowing at 254 nanometers, switched on only when a room was empty because the light was as dangerous to people as it was to pathogens. That single constraint — effective, but only when nobody's around — has shaped hospital protocols, cleaning schedules, and building design since the 1930s.
That constraint is now being challenged by a narrow sliver of the ultraviolet spectrum: 222 nanometers, commonly known as far-UVC. Unlike its 254 nm predecessor, 222 nm light is being installed directly into offices, waiting rooms, classrooms, and hospital wards — while people are still inside them. It sounds counterintuitive. It's backed by a fast-growing body of peer-reviewed research, and it's becoming one of the more closely watched technologies in infection control, indoor air quality, and industrial hygiene.
Here's what 222 nm UVC actually is, why it's different from the UVC the world has used for decades, who's adopting it, where the market is heading — and how Life Scan Medical's Anemed range fits into this shift.
What Is 222nm Far-UVC, Exactly?
Ultraviolet light is generally divided into UVA, UVB, and UVC, with UVC (100–280 nm) being the germicidal band — the part of the spectrum energetic enough to damage the DNA and RNA of viruses, bacteria, and fungi, stopping them from replicating. Conventional "germicidal UVC" sits at 254 nm, produced by low-pressure mercury lamps.
Far-UVC occupies the shorter end of that band, roughly 200–230 nm, with 222 nm — typically generated by krypton-chloride (KrCl) excimer lamps rather than mercury — emerging as the practical sweet spot. It's germicidally potent but, critically, it behaves very differently once it hits living tissue.
Why 222nm Behaves Differently From Traditional 254nm UVC
The distinction isn't marketing language; it's basic optical physics. 222 nm photons are absorbed so strongly by proteins that they penetrate only a few micrometers into any surface — including human skin and the eye. They're stopped by the outermost, already-dead layer of skin and the outer tear film and dead cells of the cornea, both of which shed and renew constantly. Traditional 254 nm UVC penetrates much deeper, reaching living skin cells and the eye's living tissue layers, which is exactly why it causes sunburn-like injury and eye irritation and has historically been restricted to unoccupied spaces or fully shielded fixtures.
A useful way to frame the difference, point by point:
Light source- Traditional 254 nm UVC comes from low-pressure mercury lamps. Far-UVC at 222 nm comes from krypton-chloride excimer lamps, which contain no mercury at all.
Penetration- 254 nm UVC reaches living skin and eye tissue. 222 nm far-UVC is absorbed within a few micrometers of the surface it hits — only the outer, already-dead layers of skin and eye.
Human occupancy- 254 nm UVC requires empty rooms, or fixtures shielded and restricted to upper-air zones. 222 nm far-UVC is designed for continuous use in occupied spaces, provided exposure stays within recognized limits.
Regulatory exposure limit- The ICNIRP exposure limit for 254 nm light is around 6 mJ/cm². For 222 nm, it's around 23 mJ/cm² — nearly four times higher, reflecting its lower tissue penetration.
Mercury content- 254 nm lamps contain mercury, an environmental and disposal concern. 222 nm excimer lamps are mercury-free.
Germicidal effectiveness- 254 nm UVC has a well-established track record dating back to the 1930s–40s. 222 nm far-UVC has shown comparable inactivation efficacy against bacteria and viruses in recent studies.
Laid out this way, the pattern is clear: far-UVC trades nothing in germicidal power, but gains the one thing 254 nm could never offer — the ability to run while people are in the room.
It's worth being balanced here rather than promotional: far-UVC isn't risk-free, and it isn't a settled scientific question. Some studies have flagged DNA-damage markers and effects on ocular cells at certain doses, and its potential to react with indoor air chemistry (forming trace ozone or secondary byproducts under specific conditions) is an active area of research. What most of the literature converges on is that, within internationally recognized exposure limits, 222 nm far-UVC used correctly is substantially safer for occupied-space use than 254 nm UVC — not that it is without any biological interaction at all. Reputable manufacturers address this by optically filtering the lamp output to isolate the 222 nm peak and suppress longer, more penetrating wavelengths that excimer lamps naturally emit alongside it.
Why Far-UVC Is Having a Moment Now
Far-UVC research isn't new — the underlying photobiology has been studied since the 2010s — but adoption has accelerated sharply for a few converging reasons:
1. A pandemic-era demand for continuous, occupied-space disinfection. COVID-19 exposed the limits of "disinfect when empty" approaches for waiting rooms, transit, and classrooms. Far-UVC was one of the few engineering controls that promised continuous pathogen inactivation without emptying the room.
2. Maturing safety data. Multi-year human studies — including long-duration monitoring of skin and eyes in occupied clinical and public settings — have built a safety record that regulators and infection-control committees are increasingly willing to act on, even as some open safety questions remain under study.
3. Regulatory and standards momentum. Building-air standards such as ASHRAE's Standard 241 on Control of Infectious Aerosols, along with updated addenda, now explicitly factor in equivalent clean-air delivery from technologies like far-UVC, giving building owners and HVAC designers a standards-based way to specify it.
4. Mercury-free lamp technology. KrCl excimer lamps eliminate mercury, aligning far-UVC systems with environmental and disposal regulations that increasingly restrict mercury-containing equipment — including older-style germicidal tubes.
5. Falling cost and improving lamp life. Early far-UVC fixtures were expensive and had short lamp lifespans. Newer filter designs (including filter-free architectures using high-purity synthetic quartz) and improved optical engineering are pushing costs down and reliability up.
Industries Putting 222nm Far-UVC to Work
Far-UVC has moved well beyond hospital pilot studies into a genuinely cross-industry technology:
Healthcare remains the anchor application — ICUs, isolation wards, dental clinics, emergency departments, and waiting rooms, where continuous air and surface disinfection in occupied spaces has the clearest clinical case. Hospitals account for the single largest share of installed far-UVC units globally.
Hospitality and transportation — airports, train stations, buses, and aircraft cabins — are adopting far-UVC to address airborne transmission risk in high-density, high-turnover environments.
Education — schools and universities are installing far-UVC in classrooms and shared spaces, partly driven by evidence linking cleaner indoor air to reduced absenteeism and better cognitive performance.
Commercial real estate and offices are integrating far-UVC into "healthy building" certifications (WELL, LEED-adjacent air-quality programs), especially as corporate landlords formalize indoor air quality as a leasing differentiator.
Food and beverage processing is an emerging high-growth segment, using far-UVC for non-thermal, chemical-free decontamination of packaging, produce, and ready-to-eat food surfaces in HACCP-compliant facilities.
Water treatment — municipal, bottled, pharmaceutical-grade, and aquaculture water systems — uses 222 nm to inactivate resistant organisms like Cryptosporidium and Giardia without the disinfection byproducts associated with chemical treatment.
Pharmaceutical and industrial cleanrooms use far-UVC, often alongside mercury-free KrCl systems, where sterility assurance and environmental compliance both matter.
The Market: Small Today, Compounding Fast
Market sizing for far-UVC varies meaningfully depending on how analysts scope the category (lamps only vs. full light-source systems vs. the broader UVC-LED market), but the direction is consistent across independent research firms: this is a small market today growing at a rapid, sustained clip.
Estimates for the global far-UVC light source/lamp market for 2025–2026 generally range from the low hundreds of millions to just over half a billion dollars, with compound annual growth rates commonly cited between roughly 13% and 26% through the early-to-mid 2030s — pushing the segment toward the region of $1–2 billion by the mid-2030s under most forecasts. Industry data suggests 222 nm far-UVC devices already represent the majority of newly installed far-UVC-class fixtures, ahead of traditional 254 nm systems and UVC-LED variants, with hospitals, schools, offices, and transit hubs together accounting for the bulk of installations. Within that, water treatment and food-and-beverage applications are flagged by multiple analysts as the fastest-growing niches, even though healthcare still dominates by volume.
The broader UVC-LED and germicidal UV lamp markets — which overlap with, but are distinct from, far-UVC specifically — are larger still, running into the billions of dollars, reflecting how germicidal UV as a category (across 222 nm, 254 nm, and LED-based sources) continues to expand across water, food processing, electronics manufacturing, and industrial disinfection.
For India and the wider Middle East/South Asia healthcare infrastructure market specifically, the direction of travel matters more than any single number: hospital accreditation bodies, infection-control committees, and increasingly ESG-conscious commercial developers are all moving toward continuous, occupied-space air and surface hygiene as a baseline expectation rather than a premium add-on — which is precisely the gap far-UVC is designed to fill.
Where Life Scan Medical and Anemed Fit In
This is exactly the shift Life Scan Medical has built into its Anemed sterilization range. Alongside Anemed's established plasma-ionization and medical-grade HEPA air sterilization systems and its portable hydrogen-peroxide/plasma/UV-C surface decontamination units, the range now incorporates 222 nm far-UVC technology into both the air and surface sterilization lines — extending the same "sterilize continuously, even while occupied" principle that far-UVC research has been validating over the past several years.
For hospitals, ICUs, operation theatres, and cleanroom environments already working with Life Scan Medical on turnkey infrastructure, that means the option of layering mercury-free, occupied-space-safe far-UVC disinfection on top of existing plasma-ionization and HEPA-based air handling — and extending the same 222 nm approach to high-touch surfaces, without needing to clear a room first. As far-UVC standards, exposure guidelines, and cost curves continue to mature globally, that positioning — building on established infection-control infrastructure rather than replacing it — is likely to matter more, not less, for facilities that need to keep pace with where hospital-grade air and surface hygiene is heading.
The Takeaway
222 nm far-UVC isn't a replacement for every existing disinfection method, and the science on its long-term safety margins is still being actively refined. But it solves a problem that 254 nm UVC never could: continuous, occupied-space germicidal protection. That single capability — disinfecting air and surfaces while people are in the room — is why healthcare, education, hospitality, food processing, and water treatment are all independently arriving at the same wavelength, and why a market barely a few hundred million dollars in size today is being forecast to grow multiple times over within the next decade.




Comments